Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

USA - NYSE:CX - US1512908898 - ADR

9.65 USD
-0.05 (-0.52%)
Last: 10/17/2025, 5:41:44 PM
9.68 USD
+0.03 (+0.31%)
After Hours: 10/17/2025, 5:41:44 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CX. CX was compared to 13 industry peers in the Construction Materials industry. While CX is still in line with the averages on profitability rating, there are concerns on its financial health. CX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CX had positive earnings in the past year.
CX had a positive operating cash flow in the past year.
CX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CX had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of 5.23%, CX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
CX has a worse Return On Equity (11.27%) than 61.54% of its industry peers.
CX has a Return On Invested Capital of 5.19%. This is in the lower half of the industry: CX underperforms 76.92% of its industry peers.
CX had an Average Return On Invested Capital over the past 3 years of 6.81%. This is below the industry average of 10.33%.
Industry RankSector Rank
ROA 5.23%
ROE 11.27%
ROIC 5.19%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With a Profit Margin value of 9.61%, CX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
CX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.30%, CX is doing worse than 76.92% of the companies in the same industry.
CX's Operating Margin has improved in the last couple of years.
The Gross Margin of CX (32.53%) is better than 76.92% of its industry peers.
In the last couple of years the Gross Margin of CX has remained more or less at the same level.
Industry RankSector Rank
OM 9.3%
PM (TTM) 9.61%
GM 32.53%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

CX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CX has an improved debt to assets ratio.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CX has an Altman-Z score of 1.52. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CX (1.52) is worse than 69.23% of its industry peers.
CX has a debt to FCF ratio of 63.21. This is a negative value and a sign of low solvency as CX would need 63.21 years to pay back of all of its debts.
CX has a Debt to FCF ratio of 63.21. This is in the lower half of the industry: CX underperforms 61.54% of its industry peers.
CX has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
CX's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. CX outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 63.21
Altman-Z 1.52
ROIC/WACC0.37
WACC13.94%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.86 indicates that CX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.86, CX is doing worse than 84.62% of the companies in the same industry.
A Quick Ratio of 0.61 indicates that CX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CX is doing worse than 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.61
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

CX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.56%.
The Earnings Per Share has been growing by 76.58% on average over the past years. This is a very strong growth
Looking at the last year, CX shows a very negative growth in Revenue. The Revenue has decreased by -25.98% in the last year.
CX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%0%
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-8.2%

3.2 Future

The Earnings Per Share is expected to decrease by -18.89% on average over the next years. This is quite bad
Based on estimates for the next years, CX will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-46.63%
EPS Next 2Y-34.66%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-4.91%
Revenue Next 2Y-0.16%
Revenue Next 3Y1.96%
Revenue Next 5Y4.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.75, the valuation of CX can be described as reasonable.
CX's Price/Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of CX to the average of the S&P500 Index (27.40), we can say CX is valued rather cheaply.
A Price/Forward Earnings ratio of 3.90 indicates a rather cheap valuation of CX.
Based on the Price/Forward Earnings ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, CX is valued rather cheaply.
Industry RankSector Rank
PE 9.75
Fwd PE 3.9
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

92.31% of the companies in the same industry are more expensive than CX, based on the Enterprise Value to EBITDA ratio.
CX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 127.86
EV/EBITDA 7.12
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as CX's earnings are expected to decrease with -18.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-34.66%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 28.23%, CX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.27, CX pays a better dividend. On top of this CX pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CX pays a better dividend.
Industry RankSector Rank
Dividend Yield 28.23%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

CX pays out 8.08% of its income as dividend. This is a sustainable payout ratio.
DP8.08%
EPS Next 2Y-34.66%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (10/17/2025, 5:41:44 PM)

After market: 9.68 +0.03 (+0.31%)

9.65

-0.05 (-0.52%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners20.96%
Inst Owner Change-0.05%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.00B
Analysts80
Price Target9.19 (-4.77%)
Short Float %1.28%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield 28.23%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP8.08%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-17 2025-09-17 (0.02238)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.18%
Min EPS beat(2)-51.46%
Max EPS beat(2)-2.91%
EPS beat(4)0
Avg EPS beat(4)-44.5%
Min EPS beat(4)-88.35%
Max EPS beat(4)-2.91%
EPS beat(8)1
Avg EPS beat(8)139.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-5.28%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-1.8%
Revenue beat(8)0
Avg Revenue beat(8)-4.42%
Revenue beat(12)1
Avg Revenue beat(12)-3.81%
Revenue beat(16)2
Avg Revenue beat(16)1.5%
PT rev (1m)4.16%
PT rev (3m)28.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)25%
EPS NY rev (3m)49.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE 9.75
Fwd PE 3.9
P/S 0.89
P/FCF 127.86
P/OCF 8.69
P/B 1.05
P/tB 3.69
EV/EBITDA 7.12
EPS(TTM)0.99
EY10.26%
EPS(NY)2.47
Fwd EY25.62%
FCF(TTM)0.08
FCFY0.78%
OCF(TTM)1.11
OCFY11.51%
SpS10.8
BVpS9.21
TBVpS2.62
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 5.23%
ROE 11.27%
ROCE 6.57%
ROIC 5.19%
ROICexc 5.54%
ROICexgc 10.25%
OM 9.3%
PM (TTM) 9.61%
GM 32.53%
FCFM 0.7%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.39%
ROIC(3y)6.81%
ROIC(5y)6.3%
ROICexc(3y)7.18%
ROICexc(5y)6.61%
ROICexgc(3y)13.44%
ROICexgc(5y)12.5%
ROCE(3y)8.62%
ROCE(5y)7.97%
ROICexcg growth 3Y3.59%
ROICexcg growth 5Y8.98%
ROICexc growth 3Y3.55%
ROICexc growth 5Y10.09%
OM growth 3Y-1.91%
OM growth 5Y2.21%
PM growth 3Y3.44%
PM growth 5Y39.71%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 63.21
Debt/EBITDA 2.21
Cap/Depr 119.14%
Cap/Sales 9.58%
Interest Coverage 250
Cash Conversion 59.27%
Profit Quality 7.27%
Current Ratio 0.86
Quick Ratio 0.61
Altman-Z 1.52
F-Score5
WACC13.94%
ROIC/WACC0.37
Cap/Depr(3y)98.23%
Cap/Depr(5y)87.02%
Cap/Sales(3y)7.21%
Cap/Sales(5y)6.61%
Profit Quality(3y)217.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.56%
EPS 3Y-35.5%
EPS 5Y76.58%
EPS Q2Q%0%
EPS Next Y-46.63%
EPS Next 2Y-34.66%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.98%
Revenue growth 3Y4.05%
Revenue growth 5Y4.29%
Sales Q2Q%-8.2%
Revenue Next Year-4.91%
Revenue Next 2Y-0.16%
Revenue Next 3Y1.96%
Revenue Next 5Y4.14%
EBIT growth 1Y-35.45%
EBIT growth 3Y2.07%
EBIT growth 5Y6.6%
EBIT Next Year57.95%
EBIT Next 3Y20.87%
EBIT Next 5YN/A
FCF growth 1Y-85.91%
FCF growth 3Y-11.58%
FCF growth 5Y-3.16%
OCF growth 1Y-23.12%
OCF growth 3Y0.91%
OCF growth 5Y6.96%